Search results for: “ide”

CPIC® guideline for statins and SLCO1B1, ABCG2, and CYP2C9 For gene-specific information tables (i.e. ABCG2 allele definition, allele functionality, and frequency tables) see guideline pages or PharmGKB.

This guideline is in progress.

Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants (April 2023) Updates since publication: None Tables provided in the main manuscript of the guideline: Table 1. Assignment of predicted phenotypes based on diplotypes Table 2. Dosing recommendations for antidepressants based on…

This guideline is in progress

Most recent guideline publication: The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms (January 2022) Updates since publication: none Tables provided in the main manuscript of the guideline: Table 1. Assignment of predicted SLCO1B1, ABCG2, and CYP2C9 likely phenotype based on genotype Table 2. Dosing recommendations for statins…

Guideline overview presentation Most recent guideline publication: Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype (August 2022) Tables  provided in the main manuscript of the guideline: Table 1. Assignment of predicted G6PD phenotype based on genotype Table 2. Drug-specific risk level and associated strength of recommendation for…

CPIC guideline for aminoglycosides based on MT-RNR1 genotype   For gene-specific information tables (i.e. MT-RNR1 allele definition, allele functionality, and frequency tables) see guideline pages or PharmGKB.

CPIC guideline for opioids based on CYP2D6, OPRM1, and COMT genotype

CPIC guideline for opioids based on CYP2D6, OPRM1, and COMT genotype

Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for MT-RNR1 and Aminoglycosides (May 2021) Updates since publication: March 2023: This update to the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides in individuals with the MT-RNR1 genotype was precipitated following contact from primary care physicians and pediatricians. These clinicians had asked…